Relationship between emotion and health: a two-way street
DOI:
https://doi.org/10.34117/bjdv9n4-019Keywords:
emotion, health, diseases, molecules, endocrine, elderly, COVID-19Abstract
Emotional reactions impact on people's health and quality of life. With the advent of neuroscience in the 1990s, much research has focused on the relationship between neural circuits and emotional reactions. In this sense, we have identified a 2031% growth in research linking emotions and health between 1990 and 2022. Using the Text mining tool called "Biotext Tools", we performed a literature search, focusing on diseases of old age and covid-19. Emotion molecules (EMs), produced by the endocrine system, impact the homeostasis of the body, affecting the biological balance of the body. We related the EMs with diseases of the elderly and Covid-19, in order to analyze the impact of emotional states on the development and treatment of these pathologies. To this end, the bidirectional relationship between anxiety, depression, heart disease, stroke, and Alzheimer's and Parkinson's diseases was analyzed. Finally, Coronavirus severity and mortality levels were related to cortisol, testosterone, and serotonin levels.
References
ABURUZ, Mohannad Eid; MASA’DEH, Rami. Gender differences in anxiety and complications early after acute myocardial infarction. Journal of Cardiovascular Nursing, v. 32, n. 6, p. 538-543, 2017.
AKIMOVA, Elena; LANZENBERGER, Rupert; KASPER, Siegfried. The serotonin-1A receptor in anxiety disorders. Biological psychiatry, v. 66, n. 7, p. 627-635, 2009.
ALBERT, Stewart G. et al. Vasopressin response to dehydration in Alzheimer's disease. Journal of the American Geriatrics Society, v. 37, n. 9, p. 843-847, 1989.
ARISTIYANI, Desty; HASNELI, Yesi; WOFERST, Rismadefi. 7. PROFILING DIABETES MELLITUS (DM) PATIENTS: DEMOGRAPHIC CHARACTERISTICS, DISEASE HISTORY AND FOOT GRADE. In: RIAU INTERNATIONAL NURSING CONFERENCE (RINC) 2018. p. 35.
AZEVEDO IM, Zayat CG, Okuma GY, Domenico EBL, Bergerot CD. Biopsychosocial symptoms in patients with incurable cancer in Brazil. Braz J Oncol. 2017;13:1-8
Bachner-Melman, Rachel, and Richard P. Ebstein. "The role of oxytocin and vasopressin in emotional and social behaviors." Handbook of clinical neurology 124 (2014): 53-68.
BAGANZ, Nicole L.; BLAKELY, Randy D. A dialogue between the immune system and brain, spoken in the language of serotonin. ACS chemical neuroscience, v. 4, n. 1, p. 48-63, 2013.
BAIXAULI GALLEGO, Elena. Happiness: role of dopamine and serotonin on mood and negative emotions. Emergency Medicine (Los Angeles), 2017, vol. 6, num. 2, p. 33-51, 2017.
BALTHAZART, Jacques; BALL, Gregory F. Is brain estradiol a hormone or a neurotransmitter?. Trends in neurosciences, v. 29, n. 5, p. 241-249, 2006.
BANKIR, Lise; BOUBY, Nadine; RITZ, Eberhard. Vasopressin: a novel target for the prevention and retardation of kidney disease?. Nature Reviews Nephrology, v. 9, n. 4, p. 223, 2013.
BATELAAN, Neeltje M. et al. Anxiety and new onset of cardiovascular disease: critical review and meta-analysis. The British journal of psychiatry, v. 208, n. 3, p. 223-231, 2016.
BODIS, J. et al. Measurement of noradrenaline, dopamine and serotonin contents in follicular fluid of human graafian follicles after superovulation treatment. Gynecologic and obstetric investigation, v. 33, n. 3, p. 165-167, 1992.
BOLL, Sabrina et al. Oxytocin and pain perception: from animal models to human research. Neuroscience, v. 387, p. 149-161, 2018.
BOMFIM, José Henrique Gialongo Gonçales; DA SILVEIRA GONÇALVES, Juliana. Suplementos alimentares, imunidade e COVID-19: qual a evidência?. VITTALLE-Revista de Ciências da Saúde, v. 32, n. 1, p. 10-21, 2020.
BREIER, Alan; BUCHANAN, Robert W. The effects of metabolic stress on plasma progesterone in healthy volunteers and schizophrenic patients. Life sciences, v. 51, n. 19, p. 1527-1534, 1992.
BREUIL, Véronique; TROJANI, Marie-Charlotte; EZ-ZOUBIR, Amri. Oxytocin and bone: review and perspectives. International Journal of Molecular Sciences, v. 22, n. 16, p. 8551, 2021.
BRYANT, Christina; JACKSON, Henry; AMES, David. The prevalence of anxiety in older adults: methodological issues and a review of the literature. Journal of affective disorders, v. 109, n. 3, p. 233-250, 2008.
BURKE, Heather M. et al. Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocrinology, v. 30, n. 9, p. 846-856, 2005.
BUSHKO, R. G. Affective medicine: Technology with emotional intelligence. Future of Health Technology, v. 80, p. 69, 2002.
CACIOPPO, John T.; BERNTSON, Gary G. The brain, homeostasis, and health: Balancing demands of the internal and external milieu. See Friedman, p. 121-137, 2011.
CAIRNEY, John et al. Comorbid depression and anxiety in later life: patterns of association, subjective well-being, and impairment. The American journal of geriatric psychiatry, v. 16, n. 3, p. 201-208, 2008.
CALDERONE, Alba et al. Selective estrogen receptor modulators in COVID-19: a possible therapeutic option?. Frontiers in Pharmacology, v. 11, p. 1085, 2020.
CARDINALI, Daniel P. et al. Melatonin and its analogs in insomnia and depression. Journal of pineal research, v. 52, n. 4, p. 365-375, 2012.
CARDOSO, Estela María del Luján et al. Dynamics of salivary cortisol in chronic kidney disease patients at stages 1 through 4. Clinical Endocrinology, v. 85, n. 2, p. 313-319, 2016.
Carlsson, Arvid, and Maria L. Carlsson. "A dopaminergic deficit hypothesis of schizophrenia: the path to discovery." Dialogues in clinical neuroscience (2022).
CHEN, Liang-Kung. Older adults and COVID-19 pandemic: Resilience matters. Archives of gerontology and geriatrics, v. 89, p. 104124, 2020.
CHRISTENSEN, Hanne; BOYSEN, Gudrun; JOHANNESEN, Helle Hjorth. Serum-cortisol reflects severity and mortality in acute stroke. Journal of the neurological sciences, v. 217, n. 2, p. 175-180, 2004.
CHUN, Ho-Yan Yvonne et al. Anxiety after stroke: the importance of subtyping. Stroke, v. 49, n. 3, p. 556-564, 2018.
CLOW, Angela; HUCKLEBRIDGE, Frank; THORN, Lisa. The cortisol awakening response in context. International review of neurobiology, v. 93, p. 153-175, 2010.
COCCARO, Emil F. Testosterone and aggression: more than just biology?. Biological psychiatry, v. 82, n. 4, p. 234, 2017.
COMBES, Guillaume F.; PELLAY, François-Xavier; RADMAN, Miroslav. Cause commune et mécanisme commun aux maladies du vieillissement?. médecine/sciences, v. 36, n. 12, p. 1129-1134, 2020.
COSTEIRA, Ricardo et al. Estrogen and COVID-19 symptoms: associations in women from the COVID Symptom Study. PLoS One, v. 16, n. 9, p. e0257051, 2021.
COWEN, Philip J.; BROWNING, Michael. What has serotonin to do with depression?. World Psychiatry, v. 14, n. 2, p. 158, 2015.
CSABA, G. The immuno-endocrine system: hormones, receptors and endocrine function of immune cells. The packed-transport theory. Advances in neuroimmune biology, v. 1, n. 1, p. 71-85, 2011.
DA COSTA, João Pinto et al. A synopsis on aging—Theories, mechanisms and future prospects. Ageing research reviews, v. 29, p. 90-112, 2016.
DALTON, Patricio S.; GHOSAL, Sayantan. Self-confidence, overconfidence and prenatal testosterone exposure: evidence from the lab. 2014.
DAMÁSIO, A. R. O erro de Descartes: emoção, razão e o cérebro humano. 2ª ed. Trad. Dora Vicente & Georgina Segurado. São Paulo: Companhia das Letras, 2006, p. 163.
DE ALMEIDA HAMMERSCHMIDT, Karina Silveira; SANTANA, Rosimere Ferreira. Saúde do idoso em tempos de pandemia COVID-19. Cogitare enfermagem, v. 25, 2020.
DE VERE, Amber J.; KUCZAJ, Stan A. Where are we in the study of animal emotions?. Wiley Interdisciplinary Reviews: Cognitive Science, v. 7, n. 5, p. 354-362, 2016.
DE VERE, Amber J.; KUCZAJ, Stan A. Where are we in the study of animal emotions?. Wiley Interdisciplinary Reviews: Cognitive Science, v. 7, n. 5, p. 354-362, 2016.
DE WINDT, L. J. et al. Molecular and genetic aspects of cardiac fatty acid homeostasis in health and disease. European heart journal, v. 23, n. 10, p. 774-787, 2002.
DEHINGIA, Nabamallika; RAJ, Anita. Sex differences in COVID-19 case fatality: do we know enough?. The Lancet Global Health, v. 9, n. 1, p. e14-e15, 2021.
DFARHUD, Dariush; MALMIR, Maryam; KHANAHMADI, Mohammad. Happiness & health: the biological factors-systematic review article. Iranian journal of public health, v. 43, n. 11, p. 1468, 2014.TENNES, K.; MASON, J.
DIEP, Phuoc-Tan; DE KOK, Véronique. Could oxytocin reduce autoimmune disease in COVID-19?. Autoimmunity Reviews, v. 21, n. 2, p. 102994, 2022.
DING, C.; LEOW, MK‐S.; MAGKOS, F. Oxytocin in metabolic homeostasis: implications for obesity and diabetes management. Obesity Reviews, v. 20, n. 1, p. 22-40, 2019.
DONOVAN, Nancy J. et al. Longitudinal association of amyloid beta and anxious-depressive symptoms in cognitively normal older adults. American Journal of Psychiatry, v. 175, n. 6, p. 530-537, 2018.
DORSZEWSKA, Jolanta et al. Serotonin in neurological diseases. Serotonin—A Chemical Messenger between All Types of living Cells; Kaneez, FS, Ed, p. 219-239, 2017.
DUBEY, Raghvendra K. et al. 17β-Estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth. Hypertension, v. 31, n. 1, p. 522-528, 1998.
Ekman P (1992) An argument for basic emotions. Cognit Emot 6:169–200
EL OUSSINI, Hajer et al. Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis. Acta neuropathologica, v. 131, n. 3, p. 465-480, 2016.
ELABD, Seham; SABRY, Ismail. Two birds with one stone: possible dual-role of oxytocin in the treatment of diabetes and osteoporosis. Frontiers in endocrinology, v. 6, p. 121, 2015.
ELNAZER, Hesham Yousry; BALDWIN, David S. Investigation of cortisol levels in patients with anxiety disorders: a structured review. Behavioral neurobiology of stress-related disorders, p. 191-216, 2014.
EMDIN, Connor A. et al. Meta-analysis of anxiety as a risk factor for cardiovascular disease. The American journal of cardiology, v. 118, n. 4, p. 511-519, 2016.
FAKHRZADEH, H.; SHARIFI, F. Cardiovascular diseases in the elderly. Journal of Gorgan University of Medical Sciences, v. 14, n. 3, p. 1-9, 2012.
FARIAS, Lucas de Pádua Gomes de; STRABELLI, Daniel Giunchetti; SAWAMURA, Márcio Valente Yamada. Pneumonia por COVID-19 e o sinal do halo invertido. Jornal Brasileiro de Pneumologia, v. 46, 2020.
FREITAS, André Ricardo Ribas; NAPIMOGA, Marcelo; DONALISIO, Maria Rita. Análise da gravidade da pandemia de Covid-19. Epidemiologia e serviços de saúde, v. 29, p. e2020119, 2020.
Gaete, Jorge Moncayo, and Julien Bogousslavsky. "Post-stroke depression." Expert review of neurotherapeutics 8, no. 1 (2008): 75-92.
GAGLIANO-JUCÁ, Thiago; BASARIA, Shehzad. Testosterone replacement therapy and cardiovascular risk. Nature Reviews Cardiology, v. 16, n. 9, p. 555-574, 2019.
GENIOLE, S. N. et al. Is testosterone linked to human aggression? A meta-analytic examination of the relationship between baseline, dynamic, and manipulated testosterone on human aggression. Hormones and behavior, v. 123, p. 104644, 2020.
GUSTAFSON, Yngve et al. Acute confusional state (delirium) soon after stroke is associated with hypercortisolism. Cerebrovascular Diseases, v. 3, n. 1, p. 33-38, 1993.
HÄUSER, Winfried et al. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. Cochrane Database of Systematic Reviews, n. 1, 2013.
HAUSS, W. H.; BAUCH, H. J.; SCHULTE, H. Adrenaline and noradrenaline as possible chemical mediators in the pathogenesis of arteriosclerosis. Annals of the New York Academy of Sciences, v. 598, p. 91-101, 1990.
HE, Matthew X.; HU, Z. B. Matrix Representations of Genetic Codes and Human Emotions. In: International Conference of Artificial Intelligence, Medical Engineering, Education. Springer, Cham, 2017. p. 23-38.
HELLHAMMER, Dirk H.; WÜST, Stefan; KUDIELKA, Brigitte M. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology, v. 34, n. 2, p. 163-171, 2009.
HELLHAMMER, Dirk H.; WÜST, Stefan; KUDIELKA, Brigitte M. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology, v. 34, n. 2, p. 163-171, 2009.
HENSLER, Julie G. Serotonin in mood and emotion. In: Handbook of behavioral neuroscience. Elsevier, 2010. p. 367-378.
HERBERT, J. Cortisol and depression: three questions for psychiatry. Psychological medicine, v. 43, n. 3, p. 449-469, 2013.
ITO, Etsuro; SHIMA, Rei; YOSHIOKA, Tohru. A novel role of oxytocin: Oxytocin-induced well-being in humans. Biophysics and physicobiology, v. 16, p. 132-139, 2019.
JANOWSKY, Jeri S. Thinking with your gonads: testosterone and cognition. Trends in cognitive sciences, v. 10, n. 2, p. 77-82, 2006.
JI, Pan et al. Association of elevated inflammatory markers and severe COVID-19: a meta-analysis. Medicine, v. 99, n. 47, 2020.
KARIO, Kazuomi; SHIMADA, Kazuyuki; PICKERING, Thomas G. Abnormal nocturnal blood pressure falls in elderly hypertension: clinical significance and determinants. Journal of cardiovascular pharmacology, v. 41, p. S61-S66, 2003.
KĘDZIORA‐KORNATOWSKA, Kornelia et al. Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patients. Journal of pineal research, v. 46, n. 3, p. 333-337, 2009.
Keltner D. Toward a consensual taxonomy of emotions. Cogn Emot. 2019 Feb;33(1):14-19. doi: 10.1080/02699931.2019.1574397. Epub 2019 Feb 22. PMID: 30795713.
KIANI, Aysha Karim et al. Neurobiological basis of chiropractic manipulative treatment of the spine in the care of major depression. Acta Bio Medica: Atenei Parmensis, v. 91, n. Suppl 13, 2020.
KIM, Yong-Ku (Ed.). Anxiety Disorders: Rethinking and Understanding Recent Discoveries. Springer Nature, 2020.
KLEINBERG, Bennett; VAN DER VEGT, Isabelle; MOZES, Maximilian. Measuring emotions in the covid-19 real world worry dataset. arXiv preprint arXiv:2004.04225, 2020.
KNAPP, Peter et al. Interventions for treating anxiety after stroke. Cochrane Database of Systematic Reviews, n. 5, 2017.
KRELL-ROESCH, Janina et al. Depressive and anxiety symptoms and cortical amyloid deposition among cognitively normal elderly persons: the Mayo Clinic Study of Aging. International psychogeriatrics, v. 30, n. 2, p. 245-251, 2018.
LA PERLE, Krista MD. Endocrine system. Pathology of Genetically Engineered and Other Mutant Mice, p. 355-377, 2021.
LAKHAN, Ram; AGRAWAL, Amit; SHARMA, Manoj. Prevalence of depression, anxiety, and stress during COVID-19 pandemic. Journal of neurosciences in rural practice, v. 11, n. 04, p. 519-525, 2020.
LANSER, Lukas et al. Testosterone deficiency is a risk factor for severe COVID-19. Frontiers in Endocrinology, v. 12, p. 694083, 2021.
LARSON, James S. The conceptualization of health. Medical care research and review, v. 56, n. 2, p. 123-136, 1999.
Lavelli, B. C., Guiesi, P. H. M., Chagas, M. H. N., & Inouye, K. (2022). Transtorno de ansiedade generalizada e desempenho cognitivo em pessoas idosas: Generalized anxiety disorder and cognitive performance in older people. Brazilian Journal of Development, 8(10), 66966–66985. https://doi.org/10.34117/bjdv8n10-143
LEACH, Sarah; SUZUKI, Kazuhiro. Adrenergic signaling in circadian control of immunity. Frontiers in Immunology, v. 11, p. 1235, 2020.
LI, Jian; HUANG, Jin-Song. Dimensions of artificial intelligence anxiety based on the integrated fear acquisition theory. Technology in Society, v. 63, p. 101410, 2020.
LI, Mingan et al. Dopamine, a co-regulatory component, bridges the central nervous system and the immune system. Biomedicine & Pharmacotherapy, v. 145, p. 112458, 2022.
LI, Tong et al. Approaches mediating oxytocin regulation of the immune system. Frontiers in immunology, v. 7, p. 693, 2017.
LIU, Jinting et al. Melatonin increases reactive aggression in humans. Psychopharmacology, v. 234, n. 19, p. 2971-2978, 2017.
LIU, Rong-Yu et al. Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression. Journal of Neuropathology & Experimental Neurology, v. 59, n. 4, p. 314-322, 2000.
LV, Wenshan et al. Low testosterone level and risk of Alzheimer’s disease in the elderly men: a systematic review and meta-analysis. Molecular neurobiology, v. 53, n. 4, p. 2679-2684, 2016.
MACHADO, Diogo et al. Biotext: Exploiting Biological-like format for text mining. bioRxiv 2021.04.08.439078; doi: https://doi.org/10.1101/2021.04.08.439078
MAMELI, S. et al. Oxytocin nasal spray in fibromyalgic patients. Rheumatology international, v. 34, n. 8, p. 1047-1052, 2014.
MAMELI, S. et al. Oxytocin nasal spray in fibromyalgic patients. Rheumatology international, v. 34, n. 8, p. 1047-1052, 2014.
Massie, Mary Jane. "Prevalence of depression in patients with cancer." JNCI Monographs 2004, no. 32 (2004): 57-71.
MAYER, Matthew L.; HANCOCK, Robert EW. Cathelicidins link the endocrine and immune systems. Cell Host & Microbe, v. 7, n. 4, p. 257-259, 2010.
MCKEIGUE, Paul M.; REYNARD, John M. Relation of nocturnal polyuria of the elderly to essential hypertension. The Lancet, v. 355, n. 9202, p. 486-488, 2000.
MDAWAR, Bernadette; GHOSSOUB, Elias; KHOURY, Rita. Selective serotonin reuptake inhibitors and Alzheimer’s disease. Neural regeneration research, v. 15, n. 1, p. 41, 2020.
MEFTAH, Imen Tayari; LE THANH, Nhan; AMAR, Chokri Ben. Towards an algebraic modeling of emotional states. In: 2010 Fifth International Conference on Internet and Web Applications and Services. IEEE, 2010. p. 513-518.
MIKHAYLOV, Alexey Y.; YUMASHEV, Alexei V.; KOLPAK, Eugeny. Quality of life, anxiety and depressive disorders in patients with extrasystolic arrhythmia. Archives of Medical Science: AMS, v. 18, n. 2, p. 328, 2022.
MÖSSNER, Rainald; LESCH, Klaus-Peter. Role of serotonin in the immune system and in neuroimmune interactions. Brain, behavior, and immunity, v. 12, n. 4, p. 249-271, 1998.
MOUCHET-MAGES, Sabine; BAYLÉ, Franck J. Sadness as an integral part of depression. Dialogues in clinical neuroscience, 2022.
NOBLE, Rudolf E. Depression in women. Metabolism, v. 54, n. 5, p. 49-52, 2005.
OH, Chang-Myung; PARK, Sangkyu; KIM, Hail. Serotonin as a new therapeutic target for diabetes mellitus and obesity. Diabetes & metabolism journal, v. 40, n. 2, p. 89-98, 2016.
OHLSSON, Claes et al. High serum testosterone is associated with reduced risk of cardiovascular events in elderly men: the MrOS (Osteoporotic Fractures in Men) study in Sweden. Journal of the American College of Cardiology, v. 58, n. 16, p. 1674-1681, 2011.
Olin, Jason T., Ira R. Katz, Barnett S. Meyers, Lon S. Schneider, and Barry D. Lebowitz. "Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background." The American Journal of Geriatric Psychiatry 10, no. 2 (2002): 129-141.
OLIVEIRA, Ana et al. Epinephrine released during traumatic events may strengthen contextual fear memory through increased hippocampus mRNA expression of Nr4a transcription factors. Frontiers in Molecular Neuroscience, v. 11, p. 334, 2018.
OLSSON, Tommy et al. Abnormalities at different levels of the hypothalamic-pituitary-adrenocortical axis early after stroke. Stroke, v. 23, n. 11, p. 1573-1576, 1992.
OUAKININ, Silvia Raquel Soares. Anxiety as a risk factor for cardiovascular diseases. Frontiers in psychiatry, v. 7, p. 25, 2016.
OUANES, Sami; POPP, Julius. High cortisol and the risk of dementia and Alzheimer’s disease: a review of the literature. Frontiers in aging neuroscience, v. 11, p. 43, 2019.
Pace-Schott EF et al. Physiological feelings. Neurosci Biobehav Rev. 2019 Aug;103:267-304. doi: 10.1016/j.neubiorev.2019.05.002. Epub 2019 May 22. PMID: 31125635.
PAL, Rimesh; BANERJEE, Mainak; BHADADA, Sanjay K. Cortisol concentrations and mortality from COVID-19. The Lancet Diabetes & Endocrinology, v. 8, n. 10, p. 809, 2020.
PAPACONSTANTINOU, John. The role of signaling pathways of inflammation and oxidative stress in development of senescence and aging phenotypes in cardiovascular disease. Cells, v. 8, n. 11, p. 1383, 2019.
PASHAEI, Yaser. Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives?. Journal of Clinical Neuroscience, v. 88, p. 163-172, 2021.
PAYNE, Jennifer L. The role of estrogen in mood disorders in women. International Review of Psychiatry, v. 15, n. 3, p. 280-290, 2003.
PÉREZ-PIÑAR, María et al. Anxiety disorders and risk of stroke: A systematic review and meta-analysis. European Psychiatry, v. 41, n. 1, p. 102-108, 2017.
PETRUCCI, Alexandra N. et al. Serotonin and sudden unexpected death in epilepsy. Experimental neurology, v. 325, p. 113145, 2020.
PIGOTT, Teresa A. Gender differences in the epidemiology and treatment of anxiety disorders. Journal of Clinical Psychiatry, v. 60, p. 4-15, 1999.
PIRHADI, Roxanna et al. Could estrogen protect women from COVID-19?. Journal of clinical medicine research, v. 12, n. 10, p. 634, 2020.
POLITIS, Marios; NICCOLINI, Flavia. Serotonin in Parkinson's disease. Behavioural brain research, v. 277, p. 136-145, 2015.
POURHAMZEH, Mahsa et al. The roles of serotonin in neuropsychiatric disorders. Cellular and Molecular Neurobiology, p. 1-22, 2021.
PUTMAN, Peter LJ. Steroids facing emotions. Utrecht University, 2006.
RAMEZANI, Mahtab et al. The role of anxiety and cortisol in outcomes of patients with Covid-19. Basic and clinical neuroscience, v. 11, n. 2, p. 179, 2020.
RAO, Yi. The first hormone: adrenaline. Trends in Endocrinology & Metabolism, v. 30, n. 6, p. 331-334, 2019.
RASH, Joshua A.; AGUIRRE-CAMACHO, Aldo; CAMPBELL, Tavis S. Oxytocin and pain: a systematic review and synthesis of findings. The Clinical journal of pain, v. 30, n. 5, p. 453-462, 2014.
RODRIGUEZ, Angela C. Incollingo et al. Hypothalamic-pituitary-adrenal axis dysregulation and cortisol activity in obesity: a systematic review. Psychoneuroendocrinology, v. 62, p. 301-318, 2015.
RUMSEY, KARLA E. Common systemic diseases in geriatric patients. American journal of optometry and physiological optics, v. 65, n. 4, p. 308-315, 1988.
RUSSELL, James A.; WALLEY, Keith R. Vasopressin and its immune effects in septic shock. Journal of innate immunity, v. 2, n. 5, p. 446-460, 2010.
SADOUL, Bastien; GEFFROY, Benjamin. Measuring cortisol, the major stress hormone in fishes. Journal of Fish Biology, v. 94, n. 4, p. 540-555, 2019.
SAMBORSKI, W. et al. Biochemical changes in fibromyalgia. Zeitschrift fur Rheumatologie, v. 55, n. 3, p. 168-173, 1996.
SANTOS, João Manoel Theotonio dos. Anxiety and Depression after Myocardial Infarction: Can Inflammatory Factors be Involved?. Arquivos brasileiros de cardiologia, v. 111, p. 684-685, 2018.
SARKAR, Chandrani et al. The immunoregulatory role of dopamine: an update. Brain, behavior, and immunity, v. 24, n. 4, p. 525-528, 2010.
SCHARFMAN, Helen E.; MACLUSKY, Neil J. The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female. Epilepsia, v. 47, n. 9, p. 1423-1440, 2006.
SEGURA‐AGUILAR, Juan et al. Protective and toxic roles of dopamine in Parkinson's disease. Journal of Neurochemistry, v. 129, n. 6, p. 898-915, 2014.
SHARMA, Drashya; FARRAR, J. David. Adrenergic regulation of immune cell function and inflammation. In: Seminars in Immunopathology. Springer Berlin Heidelberg, 2020. p. 709-717.
SHEN, Cheng-Che et al. Risk of Parkinson disease after depression: a nationwide population-based study. Neurology, v. 81, n. 17, p. 1538-1544, 2013.
SIES, Helmut. Oxidative stress: oxidants and antioxidants. Experimental Physiology: Translation and Integration, v. 82, n. 2, p. 291-295, 1997.
SKENE, Debra J.; SWAAB, Dick F. Melatonin rhythmicity: effect of age and Alzheimer's disease. Experimental gerontology, v. 38, n. 1-2, p. 199-206, 2003.
SOISSON, Véronique et al. A J-shaped association between plasma testosterone and risk of ischemic arterial event in elderly men: the French 3C cohort study. Maturitas, v. 75, n. 3, p. 282-288, 2013.
SOSA-ORTIZ, Ana Luisa; ACOSTA-CASTILLO, Isaac; PRINCE, Martin J. Epidemiology of dementias and Alzheimer’s disease. Archives of medical research, v. 43, n. 8, p. 600-608, 2012.
SOUMIER, Amélie; SIRIGU, Angela. Oxytocin as a potential defence against Covid-19?. Medical hypotheses, v. 140, p. 109785, 2020.
Sousa AR, Carvalho ESS, Santana TDS, Sousa ÁFL, Figueiredo TFG, Escobar OJV, Mota TN, Pereira Á. Men's feelings and emotions in the Covid-19 framing. Cien Saude Colet. 2020 Sep;25(9):3481-3491. English, Portuguese. doi: 10.1590/1413-81232020259.18772020. Epub 2020 Aug 28. PMID: 32876271.
Spiegel, David. "Cancer and depression." The British Journal of Psychiatry 168, no. S30 (1996): 109-116.
SRINIVASAN, V. et al. Melatonin in Alzheimer's disease and other neurodegenerative disorders. Behavioral and Brain Functions, v. 2, n. 1, p. 1-23, 2006.
SUN, Jeehae et al. Progesterone: The neglected hormone in schizophrenia? A focus on progesterone-dopamine interactions. Psychoneuroendocrinology, v. 74, p. 126-140, 2016.
SUN, Lihua; PERÄKYLÄ, Jari; HARTIKAINEN, Kaisa M. Frontal alpha asymmetry, a potential biomarker for the effect of neuromodulation on brain’s affective circuitry—preliminary evidence from a deep brain stimulation study. Frontiers in human neuroscience, v. 11, p. 584, 2017.
TAN, Tricia et al. Association between high serum total cortisol concentrations and mortality from COVID-19. The Lancet Diabetes & Endocrinology, v. 8, n. 8, p. 659-660, 2020.
TENNES, K.; MASON, J. Developmental psychoendocrinology: An approach to the study of emotions. Measuring emotions in infants and children, p. 21-37, 1982.
THAKUR, Pratibha; SHRIVASTAVA, Renu; SHRIVASTAVA, Vinoy K. Oxytocin as a potential adjuvant against COVID-19 infection. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders), v. 21, n. 7, p. 1155-1162, 2021.
THYAGARAJAN, Srinivasan; PRIYANKA, Hannah P. Bidirectional communication between the neuroendocrine system and the immune system: relevance to health and diseases. Annals of Neurosciences, v. 19, n. 1, p. 40, 2012.
TONI, R. The neuroendocrine system: organization and homeostatic role. Journal of endocrinological investigation, v. 27, n. 6 Suppl, p. 35-47, 2004.
TRIARHOU, Lazaros C. Dopamine and Parkinson's disease. In: Madame Curie Bioscience Database [Internet]. Landes Bioscience, 2013.
URSINI, Fulvio; MAIORINO, Matilde; FORMAN, Henry Jay. Redox homeostasis: The Golden Mean of healthy living. Redox biology, v. 8, p. 205-215, 2016.
VAN BALKOM, Anton JLM et al. Comorbidity of the anxiety disorders in a community‐based older population inThe Netherlands. Acta Psychiatrica Scandinavica, v. 101, n. 1, p. 37-45, 2000.
VAN VOLLENHOVEN, Ronald F.; MCGUIRE, James L. Estrogen, progesterone, and testosterone: can they be used to treat autoimmune diseases?. Cleveland Clinic journal of medicine, v. 61, n. 4, p. 276-284, 1994.
VIGEN, Rebecca et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. Jama, v. 310, n. 17, p. 1829-1836, 2013.
Vogelzangs, Nicole, Aartjan TF Beekman, Yuri Milaneschi, Stefania Bandinelli, Luigi Ferrucci, and Brenda WJH Penninx. "Urinary cortisol and six-year risk of all-cause and cardiovascular mortality." The Journal of Clinical Endocrinology & Metabolism 95, no. 11 (2010): 4959-4964.
WEINER, Myron F. et al. Cortisol secretion and Alzheimer’s disease progression. Biological psychiatry, v. 42, n. 11, p. 1030-1038, 1997.
WILLING, Ben et al. Twin studies reveal specific imbalances in the mucosaassociated microbiota of patients with ileal Crohn's disease. Inflammatory bowel diseases, v. 15, n. 5, p. 653-660, 2009.
WOOD, Patrick B. et al. Changes in gray matter density in fibromyalgia: correlation with dopamine metabolism. The Journal of Pain, v. 10, n. 6, p. 609-618, 2009.
WOOD, Patrick B. et al. Fibromyalgia patients show an abnormal dopamine response to pain. European Journal of Neuroscience, v. 25, n. 12, p. 3576-3582, 2007.
YANG, Hai-Peng et al. Nonsocial functions of hypothalamic oxytocin. International Scholarly Research Notices, v. 2013, 2013.
YASSIN, Aksam et al. Testosterone and Covid‐19: An update. Reviews in Medical Virology, p. e2395, 2022.
ZHAO, Zi-Yan et al. Cortisol secretion in the elderly. Influence of age, sex and cardiovascular disease in a Chinese population. Steroids, v. 68, n. 6, p. 551-555, 2003.
ZHU, Xiangjia et al. Intraoperative Pain Sensation During Cataract Surgery: Why Does Timing Matter?. Current Eye Research, v. 46, n. 7, p. 971-977, 2021.
ZINK, Caroline F. et al. Vasopressin modulates medial prefrontal cortex–amygdala circuitry during emotion processing in humans. Journal of Neuroscience, v. 30, n. 20, p. 7017-7022, 2010.
